Endocannabinoid
EndogenousOEAOleoylethanolamide
(Z)-N-(2-hydroxyethyl)octadec-9-enamide
Aliases.oléoyléthanolamide · N-oléoyléthanolamine · N-oleoylethanolamine · N-(2-hydroxyéthyl)oléamide · 18:1 NAE
The N-acylethanolamine of satiety, an endogenous ligand of the PPAR-α receptor.
Updated on
Level of detail
Identifiers
- Formula
- C₂₀H₃₉NO₂
- Molar mass
- 325.50 g·mol⁻¹
- CAS
- 111-58-0
- PubChem CID
- 5283454
- First described
- Décrit comme médiateur lipidique de la satiété par l'équipe de Daniele Piomelli au début des années 2000, au sein de la famille des N-acyléthanolamines endogènes.
- Origin
- An endogenous molecule present in mammals, produced notably in the mucosa of the small intestine. Also offered as a food supplement.
- InChIKey
- BOWVQLFMWHZBEF-KTKRTIGZSA-N
In plain terms
A molecule cousin to the endocannabinoids, naturally made by the intestine after meals and associated with the sensation of satiety.
Receptors and activity
- PPAR-αLigand endogène de haute affinité du récepteur nucléaire PPAR-αAgonist
- GPR119Agonist
- TRPV1Agonist
- CB1Affinité négligeable pour les récepteurs cannabinoïdes CB1/CB2Modulator
- Agonist
- Partial agonist
- Antagonist
- Modulator
- Inverse agonist
Hover over a row for the precise value (Ki, EC50…)
Subjective signature
Hover over an axis to read its definition.
- Calm30
- Clarity20
- Sleep25
- Appetite10
- High15
Editorial estimate, not clinical.
Pharmacology
Oleoylethanolamide (OEA) is an endogenous N-acylethanolamine, a congener of anandamide and the oleic analogue of PEA. Despite this kinship, it barely activates the CB1 and CB2 cannabinoid receptors: its mechanism rests chiefly on activation of the nuclear receptor PPAR-α, of which it is a high-affinity endogenous ligand, with a contribution from the GPR119 receptors and the TRPV1 channel. Produced in the small intestine in response to feeding, it acts as a local lipid satiety signal transmitted by vagal afferents.
Key sources.
- PubChem CID 5283454 : Oleoylethanolamide
- GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, OEA and PEA (Int. J. Mol. Sci. 2021)
- Central mechanisms mediating the hypophagic effects of oleoylethanolamide (Front. Pharmacol. 2015)
- A systematic review of OEA, a high-affinity endogenous ligand of PPAR-α (Clin. Exp. Pharmacol. Physiol. 2020)
Biosynthetic pathway (in vivo)
Oleoylethanolamide is synthesised on demand in cell membranes: a phospholipid precursor, N-oleoyl-phosphatidylethanolamine (NAPE), is cleaved by a specific phospholipase D (NAPE-PLD) that releases OEA. Its intestinal production is stimulated by dietary fat intake. It is then degraded by fatty acid amide hydrolase (FAAH), the same enzyme as for anandamide.
Legal framework
France
OEA is an endogenous molecule (naturally present in the body) and is not classified as a narcotic in France. It does not share the benzo[c]chromene core of the THC-type derivatives covered by the ANSM Decision of 22 May 2024 and escapes that framework. It is offered on the market as a food supplement.
European Union
Unscheduled at European level; an endogenous substance marketed as a food supplement, with no narcotic status.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Structural classification
- Class
- Endocannabinoid
- Origin
- An endogenous molecule present in mammals, produced notably in the mucosa of the small intestine. Also offered as a food supplement.
- Status
- Endogenous
N-acyléthanolamine (NAE) mono-insaturée : l'acide oléique (C18:1, cis-9) lié par une fonction amide à l'éthanolamine. C'est le congénère mono-insaturé de l'anandamide (AEA) et l'analogue oléique du palmitoyléthanolamide (PEA).
Pharmacokinetics
Médiateur lipidique produit et agissant localement, à demi-vie courte : il est rapidement hydrolysé par la FAAH, ce qui limite sa durée d'action après une libération endogène.
Metabolism
Dégradé par hydrolyse enzymatique via la FAAH (et, accessoirement, la NAAA), qui scinde la liaison amide en acide oléique et éthanolamine.
References
- 1.PubChem CID 5283454 : Oleoylethanolamide
- 2.GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, OEA and PEA (Int. J. Mol. Sci. 2021)
- 3.Central mechanisms mediating the hypophagic effects of oleoylethanolamide (Front. Pharmacol. 2015)
- 4.A systematic review of OEA, a high-affinity endogenous ligand of PPAR-α (Clin. Exp. Pharmacol. Physiol. 2020)
Structured data
- InChIKey
- BOWVQLFMWHZBEF-KTKRTIGZSA-N
- SMILES
- CCCCCCCC/C=C\CCCCCCCC(=O)NCCO
- Formula
- C20H39NO2
- Molar mass
- 325.50 g·mol⁻¹
- CAS
- 111-58-0
- PubChem CID
- 5283454
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.